mark: european close, get back to davos, david is standing by with andrew liveris. chief executive and chairman of the world's biggest chemical company, or at least one of them. dow chemical. david, over to you. david: thanks very much, mark. thank you very much for joining us, andrew. even though it's chilly. andrew: yes. breath coming. david: last time we spoke, it was the day you announced dupont. bring us up to date on that merger. where does it stand now? andrew: look, we had 30 or so days. the team's are working very much to put together sninnering programs. things we are allowed to do until we close. we call them program management offices. we are putting people to those. and i -- he and i co-chair. remember, this is a pretty specialty on many respects because of the spins that will occur. we are also working the teams on getting these companies ready for spins. there is a limited amount we can do now. that amount of work probably will accelerate after day one. if everything goes to plan, lots of variables out there, but back half of the year close. kicks, 12

short-term, as ceo, andrew liveris tells us, investors don't want to own the best of them. a short-term bottom. we are the most oversold we have been in many months. maybe oil can bounce. maybe china can do something right. speculating, buying stocks has been the single worst strategy of 2016. they have every right to speculate. some of our biggest wins here have come from speculating with low price stocks. consider that more than ten years ago, i bought the ceo for general, i brought hip on the show when the stock was a $5 stock. today, it is at $475. we talked about a revolutionary drug. they could work wonders against a nasty eye disease called macular degeneration. the standard of care was giving patients a weekly injection in the eye. to one injection a month, not one a week. i would in disbelief. i merely suggested that regeneron would be a terrific stock to speculate on. it turned out to be a good tip. i urged you to buy perspectives with a rich takeover bid from celgene. right now, i would tell you with the current set of circumstances, i would have been reluctant t

joining us now is the ceo, andrew liveris. thanks for joining us.e benefits and corporations which i'm going to get to in a moment. first the talk about the global economy considering this is front and center. how do you see things? >> maria, the oil price scenario through 2015 and the general commodities issue that has occurred is heard in emerging economies in terms of revenue streams. we have always had the portfolio should initiative from low-priced commodities if we have value add input/outputs, which means technology and products people buy no matter what happens to the economic situation. we see that. they are low commodity prices. it is slower than what would otherwise see. clearly, a big chunk of the gasoline price went down into savers pockets first, but it's coming out of the pocket now. maria: i have been trying to track this and it doesn't feel like people are spending money they saved. >> talk to the car manufacturers, furniture and bedding manufacturers who we sold two. this is a global conversation i'm having with you. we see a pivot